Technical Insights

Trace Amine Impurity Thresholds in 1,1-Cyclohexanediacetic Acid Monoamide for High-Yield Acylation

GC-MS vs. Titration: Quantifying Trace Amine Impurities in 1,1-Cyclohexanediacetic Acid Monoamide for Catalyst Compatibility

Chemical Structure of 1,1-Cyclohexanediacetic Acid Monoamide (CAS: 99189-60-3) for Trace Amine Impurity Thresholds In 1,1-Cyclohexanediacetic Acid Monoamide For High-Yield AcylationIn the synthesis of Gabapentin, the intermediate 1,1-cyclohexanediacetic acid monoamide (also known as 3-3-Pentamethylene glutaramic acid) must meet stringent purity profiles to ensure high-yield acylation steps. Trace amine impurities, often originating from incomplete amidation or degradation, can poison Lewis acid catalysts like AlCl₃, leading to reduced yields and increased byproducts. At NINGBO INNO PHARMCHEM, we employ orthogonal analytical methods to quantify these impurities. While titration (e.g., non-aqueous acid-base) provides a rapid total amine number, it lacks the specificity to differentiate primary amines from secondary or tertiary amines that may co-elute. GC-MS, after derivatization with trifluoroacetic anhydride, allows identification and quantification of individual amine species down to 50 ppm. For procurement managers, requesting a COA that includes both total amine by titration and a GC-MS impurity profile is critical. Our 1,1-cyclohexanediacetic acid monoamide consistently shows total amines below 0.1% and no single unspecified amine above 0.05%, ensuring compatibility with sensitive acylation catalysts. This dual approach mitigates the risk of catalyst deactivation, which is especially important when scaling from lab to industrial production.

Volatile Organic Thresholds and Their Impact on Acylation Yield: A Data-Driven COA Validation Framework

Volatile organic impurities (VOIs) in 1,1-cyclohexanediacetic acid monoamide, such as residual solvents from the manufacturing process (e.g., toluene, isopropanol), can interfere with acylation reactions by competing for the acylating agent or altering reaction kinetics. A rigorous COA validation framework must include headspace GC-MS analysis with limits aligned to ICH Q3C guidelines. For instance, residual isopropanol above 500 ppm can lead to ester formation during acylation, reducing the yield of the desired Gabapentin intermediate. Our process, detailed in the article on preventing filter cake compaction during isopropanol isolation, minimizes solvent entrapment, resulting in typical residual isopropanol levels below 200 ppm. The table below compares typical impurity profiles from different sources, highlighting the importance of a comprehensive COA.

ParameterINNO PHARMCHEM TypicalCompetitor A (TRC Standard)Acceptance Criteria
Purity (HPLC)≥99.0%≥98.0%≥98.5%
Total Amines (Titration)≤0.1%Not reported≤0.2%
Residual Isopropanol≤200 ppmNot specified≤500 ppm
Water (Karl Fischer)≤0.5%Not specified≤1.0%
Heavy Metals (ICP-MS)≤10 ppmNot specified≤20 ppm

By adopting a data-driven COA validation framework, procurement teams can ensure that the 1,1-cyclohexanediacetic acid monoamide meets the required thresholds for high-yield acylation, avoiding costly batch rejections.

Non-Standard Parameter Alert: Viscosity and Crystallization Behavior of 1,1-Cyclohexanediacetic Acid Monoamide Under Sub-Ambient Storage

Field experience reveals that 1,1-cyclohexanediacetic acid monoamide exhibits a marked increase in viscosity at temperatures below 5°C, transitioning from a free-flowing powder to a semi-solid mass. This behavior, not typically captured on standard COAs, can complicate material handling and accurate dispensing in cold warehouses. The compound's tendency to form a glassy state rather than a true crystalline solid is attributed to its molecular structure—a cyclohexane ring with two acetic acid/amide side chains that hinder close packing. In practice, if drums are stored at -20°C (as recommended by some suppliers for long-term stability), the material may require warming to room temperature and mechanical agitation before use. Our stability studies, discussed in bulk 1,1-cyclohexanediacetic acid monoamide moisture control, show that while chemical degradation is minimal at low temperatures, the physical form change can lead to moisture uptake if containers are opened while cold, accelerating hydrolysis. Therefore, we recommend storage at 2–8°C and allowing 24 hours for equilibration to ambient temperature before opening. This non-standard parameter is crucial for production planning in regions with cold climates.

Bulk Packaging and Supply Chain Integrity: IBC and Drum Specifications for High-Purity Amide Intermediates

For industrial-scale procurement, packaging integrity directly impacts the quality of 1,1-cyclohexanediacetic acid monoamide upon arrival. We supply this intermediate in 210L HDPE drums with double LDPE liners and nitrogen purging, or in 1000L IBCs for bulk orders. The choice between drum and IBC depends on consumption rate and facility handling capabilities. IBCs offer lower per-kg packaging costs and reduced manual handling, but require dedicated dispensing systems to avoid moisture ingress. Our drums are UN-rated for solid chemicals and include tamper-evident seals. To maintain the low moisture levels critical for acylation yield (as hydrolysis of the amide can generate the diacid impurity), we include desiccant bags in each drum and recommend that end-users perform a Karl Fischer test upon receipt. The logistics chain from our GMP facility ensures a stable supply, with typical lead times of 4–6 weeks for custom quantities. For drop-in replacement of existing sources, our product matches the physical form (white crystalline powder) and packaging configurations, minimizing requalification efforts.

Frequently Asked Questions

What are the acceptable ppm ranges for specific amine contaminants in 1,1-cyclohexanediacetic acid monoamide?

Acceptable limits depend on the acylation catalyst sensitivity. For AlCl₃-catalyzed reactions, total primary amines should be below 1000 ppm, with no single amine (e.g., cyclohexylamine) above 200 ppm. Our COA typically shows total amines <1000 ppm and cyclohexylamine <100 ppm. Please refer to the batch-specific COA for exact values.

How does 1,1-cyclohexanediacetic acid monoamide cross-react with acyl chlorides?

The primary amide group can react with acyl chlorides to form imides under forcing conditions, but under typical acylation conditions (e.g., Friedel-Crafts), the amide is less reactive than the carboxylic acid. However, trace amines can form amides with the acyl chloride, consuming reagent and reducing yield. This is why low amine content is critical.

What validation protocols are recommended for incoming batch acceptance of this intermediate?

We recommend identity by IR or NMR, purity by HPLC (≥98.5%), total amines by titration, residual solvents by GC, water by KF, and appearance (white to off-white powder). A heavy metals screen by ICP-MS is advised for pharmaceutical use. Our COA includes all these tests.

What is 1,1-cyclohexane diacetic acid?

1,1-Cyclohexane diacetic acid is the diacid precursor to the monoamide. It is a key impurity to monitor, as it can form during hydrolysis of the monoamide. In acylation, the diacid can lead to cross-linked byproducts. Our monoamide typically contains <0.5% diacid.

Sourcing and Technical Support

As a global manufacturer of 1,1-cyclohexanediacetic acid monoamide, NINGBO INNO PHARMCHEM provides a reliable, cost-effective drop-in replacement for your Gabapentin intermediate needs. Our product meets identical technical parameters to major brands, with enhanced supply chain transparency and batch-to-batch consistency. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.